Investor Presentaiton

Growth Platforms: Three Issues Leadership Teams 00 30 Rare Disease Pricing and value in small populations Patient finding/tracking Unique go-to-market challenges Disruption in Life Sciences Anticipating technological change (e.g., curative therapies) Regulatory and market disruptions (e.g., HTA approaches) Commercial innovation (e.g., business model shifts) Life Sciences 2030 Digital strategy Patient empowerment 2030 critical success factors CRA Charles River Associates

View entire presentation